JQEZ-5
CAS No. 1913252-04-6
JQEZ-5 ( EZ-005;EZ005;JQEZ5 )
Catalog No. M12997 CAS No. 1913252-04-6
A novel potent, selective, SAM-competitive EZH2 inhibitor with IC50 of 80 nM (inhibition of enzymatic function of PRC2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 80 | In Stock |
|
10MG | 115 | In Stock |
|
25MG | 236 | In Stock |
|
50MG | 441 | In Stock |
|
100MG | 644 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJQEZ-5
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, selective, SAM-competitive EZH2 inhibitor with IC50 of 80 nM (inhibition of enzymatic function of PRC2).
-
DescriptionA novel potent, selective, SAM-competitive EZH2 inhibitor with IC50 of 80 nM (inhibition of enzymatic function of PRC2); demonstrates acutely reduced level of H3K27me3 without affecting mono- and di-methylation, suppresses the proliferation of EZH2-overexpression H661 and H522 cell lines, more effectively than GSK-126 and GSK-343; promotes the regression of EZH2-driven tumors in vivo.
-
SynonymsEZ-005;EZ005;JQEZ5
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1913252-04-6
-
Formula Weight542.69
-
Molecular FormulaC30H38N8O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 25 mg/mL 46.07 mM;H2O : < 0.1 mg/mL
-
SMILESCC(C)N1N=CC2=C(C=C(N=C12)C3=CC=C(N4CCN(CC4)C)N=C3)C(NCC5=C(CCC)C=C(C)NC5=O)=O
-
Chemical NameN-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. Cancer Discov. 2016 Sep;6(9):1006-21.
2. Frankel AE, et al. Cancer Discov. 2016 Sep;6(9):949-52.
2. Frankel AE, et al. Cancer Discov. 2016 Sep;6(9):949-52.
molnova catalog
related products
-
CMP-5 hydrochloride
CMP-5 (PRMT5-IN-5)is a first-in-class, small-molecule PRMT5-specific inhibitor that blocks EBV-driven B-lymphocyte transformation and survival.
-
CM-272
CM-272 (CM272)is a novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 8 nM and 382 nM for G9a and DNMT1, respectively.
-
XY1
XY1 is the inactive control compound of SGC-707.